8-K

Company

Aurinia Pharmaceuticals Inc.

Filed

March 23, 2026

Period of Report

March 20, 2026

Accession Number

0001600620-26-000026

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →